IFCC recommendation: The theory of reference values. Part 4. Control of
analytical variation in the production, transfer and application of reference values by Solberg, Helge Erik & Stamm, D.
Journal of Automatic Chemistry, Vol. 13, No. 5 (September-October 1991), pp. 231-234
International Federation of Clinical Chemistry (IFCC)
IFCC recommendation: The theory of
reference values. Part 4. Control of
analytical variation in the production,
transfer and application of reference values*
Helge Erik Solberg
Department Clinical Chemistry, Rikshospitalet, N-0027 Oslo 1, Oslo, Norway
and D. Stamm
Department of Clinical Chemistry, Max-Planck Institute ofPsychiatry, Munich,
Germany
This paper is the fourth in a series of Recommendations on the
Theory of Reference Values. The others cover:
Part 1. The Concept of Reference Values [1].
Part 2. Selection ofIndividualsfor the Production ofReference
Values [2].
Part 3. Preparation ofIndividuals and Collection ofSpecimens
for the Production ofReference Values [3].
Part 5. Statistical Treatment of Collected Reference Values.
Determination ofReference Limits [4].
Part 6. Presentation of Observed Values Related to Reference
Values [5].
A Guide to the Documents is currently in preparation.
The Expert Panel of Theory ofReference Values (EPTR V) was
created in 1970 by the Committee on Standards (at present:
Scientific Division) of the International Federation of Clinical
Chemistry (IFCC). Its task was to develop a nomenclature and
recommend procedures for the production of reference values and
their treatment, and presentation of observed values in relation to
reference data.
The first document in the above-mentioned series describes the
subject of reference values and defines various terms. It would be
best to read itfor a thorough understanding ofthepresent document.
1. Introduction
1.1. Aim of the document
Observed values may be compared with reference values
or with the reference distribution, reference limits and
reference interval derived from the reference values 1,5].
Reprint requests and enquiries to: Dr Helge Erik Solberg.
Members of the Expert Panel on the Theory of Reference Values
during the preparation of this recommendation were as follows: R.
Grisbeck (FI) 1970-1978 (Chairman 1975-1978), N. Montalbetti (IT)
1982-1986, C. PetitClerc (CA) 1977-1986, H. E. Solberg (NO) 1977-
1986 (Chairman since 1979), G. Siest (FR) 1973-1979, D. Stamm (DE)
1979-1986, P. Wilding (US) 1976-1984.
The purpose of this document is to provide guidance on
the requirements necessary to ensure that the reference
values are produced using accurate and precise methods.
Failure to employ methods that have known and suitably
low levels of inaccuracy and imprecision will reduce the
clinical utility of the results.
1.2. Perspective
It is important to establish and maintain a realistic
awareness of the contribution that analytical inaccuracy
and imprecision may have on the production of reference
values. Biological variance is an important factor to take
into consideration when determining allowable impre-
cision and inaccuracy [6-8]. Thus, serious efforts should
be made to establish the tolerable levels of analytical
inaccuracy and imprecision for the intended uses of the
reference values. For example, the Aspen Conference
defined in 1976 the tolerable levels of imprecision for
measurements of calcium and urea in serum to be quite
different, 0"9% and 6"2% (CV), respectively [6].
This document assumes that an adequate effort has been
made to reduce biological variation when selecting
subjects [2] and collecting specimens [3].
1.3. Needfor reliable methods
The method, including the reagents and equipment used,
must be described in enough detail that adequately-
trained analysts will all proceed in the same manner and
obtain reproducible results. The assessment of these
methods should be made according to Part 2 of the
recommendations of the IFCC’s Expert Panel on
Nomenclature and Principles of Quality Control [9].
1.4. Needfor long-term stability of the analytical method
The development ofreference values is a time-consuming
and costly exercise. As a result, it is essential that the
values must have application over a lengthy period.
Furthermore, the true clinical utility of the values in
diagnosis, comparative assessment and long-term moni-
toring necessitates the use of well-controlled analytical
procedures.
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1.5. Experimental design
In the production of reference values it is desirable to
keep analytical variance of approximately the same
magnitude as that obtained by good-quality routine
analysis. Therefore, it is strongly recommended that the
measurements for the production of reference values be
made under strictly controlled, but realistic routine
conditions, including the day-to-day imprecision.
1.6. Transferability
The complexity, cost and effort of establishing reference
values are often minimal when compared with the
problem of obtaining a sufficient number of adequate
specimens for the production ofthe reference values. As a
result it is often necessary to transfer reference values
from one institution to another. In this case it is essential
that the laboratories involved obtain comparable results;
this can be achieved by assessment of the accuracy and
precision of the analytical method in use through long-
term inter-laboratory studies 10].
Comparability of results is also necessary for laboratories
receiving specimens from mobile populations. It may be
best achieved using similar analytical procedures. Should
they be different, it is important that they conform to
tolerable limits of inaccuracy and imprecision.
2. Monitoring procedures
2.1. The theoretical principles underlying quality control
(QC) and the various forms that QC can take are treated
in detail in the recommendation of the Expert Panel on
Nomenclature and Principles of Quality Control in
Clinical Chemsitry [9].
There are numerous QC procedures which will monitor
the accuracy and precision ofthe analyses, and ensure the
transferability of the data. This section provides elemen-
tary guidance in QC procedures for this purpose. It is
assumed that laboratories performing this work will have
certain materials and facilities available which will,
probably, be in use routinely. However, it is essential that
the following conditions are met:
The calibration material must be carefully defined [9,11 ],
keeping in mind the presence ofnonspecfic components
which may contribute to the reading.
The basis for calculation, for example molar lineic
absorbance [9,11], must be carefully defined and
tested.
Suitable control specimens must be available commer-
cially or be prepared by the user. They should have a
matrix that has properties similar to those of the
specimens used for the production of reference values
[7-11]. To ensure proper monitoring of accuracy,
precision and reliability of a method, selected control
materials should be validated [10].
The control procedure should be described in detail. This
description should also include decision rules for out-
of-control situations and reactions to alarms [12].
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2.2. Recommendation for single laboratories
In most cases, a simple system involving control speci-
mens is recommended for this purpose [9]. The recom-
mended system [13,14] consists of internal and external
quality control procedures, see figure 1. (External quality
control is also called ’external quality assessment’.)
The procedures for the two separate kinds of internal
control, control of precision and control of accuracy, are
shown in figure 2.
In accuracy control, it is important that the whole
clinically relevant interval ofmeasurement be monitored.
In some cases control rules are needed that are more
sensitive to inaccuracy and imprecision than those
described in figures and 2. For example, it is important
to detect small increases in inaccurcy and imprecision of
the analysis of the concentration of calcium in serum
because of the small biological variance of this compo-
nent. Westgard, Groth and coworkers have developed
control systems that help to ensure that the analytical
quality is within stated limits 12,15].
2.3. Recommendationfor multiple laboratory collaboration
Ifseveral laboratories are to participate in the production
of reference values, the comparability of the results from
these laboratories must first be evaluated. If compar-
ability is inadequate, appropriate changes must be made
in the analytical system. Whenever several laboratories
are involved, there must be continuing checks on
comparability while reference values are being produced.
Prior to analysing the specimens from the reference
individuals, the laboratories should assess the compar-
ability oftheir analytical results by using the same control
material. Where stability of the component permits, it is
also advisable to check comparability by exchanging
human specimens. An effective model for conducting and
evaluating such a long-term survey has been developed,
and experience with the model has been reported 10]. If
Internal quality control
Control of precision
In every run of analyses, even if the run consists of only
one patient specimen
with precision control specimen
Control of inaccuracy
in at least every fourth run
with accuracy control specimen
External quality control (or assessment)
Interlaboratory surveys
at least three times a year for each type of quantity
specimens shipped by the chief investigator
--evaluation on the basis on analytical results from
independent reference laboratories
Figure 1. Basic programfor quality control.H. E. Solberg and D. Stamm The theory of reference values--Part 4
Control ofprecision Control ofaccuracy





A precision control specimen from a batch
used for as long a time as possible
Concentration at the decision limit
Form for assessment of accuracy
One of a number of different accuracy
control specimens kept on hand
Assigned values at normal and
pathological levels




Does not know concentration (known to
control supervisor of the laboratory)
Goals Assessment of random variation (random
errors)
Detection of trends
Detection of systematic deviations
(systematic errors)
Monitoring over the whole diagnostically
relevant interval
Detection of influence of other components
(matrix)
Elimination of intentional or unintentional
misinterpretation of data by analyst
Figure 2. Recommended basic internal quality control.
the data from the comparison study shows that no
significant effect on the size of the reference interval will
be the result, then a multi-laboratory study can proceed.
3. Transfer of reference value data
The diversity of analytical procedures has complicated
the establishment oftransferable reference values. There-
fore, using the QC procedures above with well operated
and documented methodology is a prerequisite for the
transfer of reference value data from one laboratory to
another. However, it is important to realize that the
clinical environment is dynamic, and that reference
values and associated data may become invalid or
inappropriate over a period of time. To prevent the
obsolescence of reference value data it is imperative to
ensure the following:
(a) Monitor changes in method accuracy and
precision.
(b) Check relevance of reference value data with the
individuals and/or groups being assessed.
(c) Store the original reference value data.
(d) Update reference value information when
necessary.
5. Appendix: Methods of quality control
A simple procedure for the control of accuracy and
precision is shown in figures and 2.
5.1. Accuracy control
It is essential to detect changes in the calibration curve
over time and to monitor the accuracy of the analytical
method. This requires a number of accuracy control
specimens at both normal and pathological concen-
trations. These control specimens shoud contain different
kinds of matrix, and should also contain other com-
ponents that might disturb the analysis. Accuracy and
specificity will not be monitored adequately if the
different concentrations of the target component are
obtained by spiking the same matrix, or by adding
different amounts of diluent to the same amount of the
specimen during reconstitution.
5.2. Precision control
To ensure that the required precision is maintained and
to detect trends, it is recommended that an adequate
number of control specimens be included at fixed or
random positions in each analytical run [7,8]. Ideally,
precision control should be employed at different con-
centrations. If only one precision control is used, the
concentration should match the clinical discrimination
level.
4. Comment
Figures and 2 are intended for guidance and do not
constitute the only effective methods of controlling and
monitoring analytical variation.
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